Endoscopic clipping versus inlection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis

Sung, Joseph J. Y.; Tsoi, Kelvin K. F.; Lai, Larry H.; Wu, Justin C. Y.; Lau, James Y. W.
October 2007
Gut;Oct2007, Vol. 56 Issue 10, p1364
Academic Journal
Background: Hemoclips, injection therapy and thermocoagulation (heater probe or electrocoagulation) are the most commonly used types of endoscopic hemostasis for the control of non-variceal gastrointestinal bleeding. Aim: To compare the efficacy of hemoclips versus injection or thermocoagulation in endoscopic hemostasis by pooling data from the literature. Method: Publications in the English literature (MEDLINE, EMBASE and Cochrane Library) as well as abstracts in major international conferences were searched using the keywords ‘hemoclips’ and ‘bleeding’, and 15 trials fulfilling the search criteria were found. Outcome measures included: initial hemostasis (after endoscopic intervention); recurrent bleeding; definitive hemostasis (no recurrent bleeding until the end of follow-up); the requirement for surgical intervention; and all-cause mortality. The heterogeneity of trials was examined and the effects were pooled by meta-analysis. Results: Of 1156 patients recruited in the 15 studies, 390 were randomly assigned to receive clips alone, 242 received clips combined with injection, 359 received injection alone, and 165 received thermocoagulation with or without injection. Definitive hemostasis was higher with hemoclips (86.5%) than inlection (75.4%; RR 1.14, 95% CI 1.00-1 .30), or endoscopic clips with injection (88.5%) compared with injections alone (78.1%; RR 1.13, 95% CI 1.03-1.23), leading to a reduced requirement for surgery but no difference in mortality. Compared with thermocoagulation, there was no improvement in definitive hemostasis with clips (81.5% versus 81.2%; RR 1.00, 95% CI 0.77-1.31). These estimates were robust in sensitivity analyses. There was also no difference between clips and thermocoagulation in rebleeding, the need for surgery and mortality. The reported locations of failed hemoclip applications included posterior wall of duodenal bulb, posterior wall of gastric body and lesser curve of the stomach. Conclusion: Successful application of hemoclips is superior to injection alone but comparable to thermocoagulation in producing definitive hemostasis. There was no difference in all-cause mortality irrespective of the modalities of endoscopic treatment.


Related Articles

  • Computed Virtual Chromoendoscopy - Enhanced Videocapsule Endoscopy is of Potential Benefit in Gastric Antral Vascular Ectasia Syndrome Refractory to Endoscopic Treatment. Rimbas, Mihai; Haidar, Andrei; Voiosu, Mihail Radu // Journal of Gastrointestinal & Liver Diseases;Sep2011, Vol. 20 Issue 3, p307 

    Gastric antral vascular ectasia (GAVE) syndrome represents a rare cause of gastrointestinal bleeding. More extensive small-bowel involvement must be excluded in those patients with GAVE syndrome in whom aggressive endoscopic treatment of antral lesions results in lack of control of digestive...

  • In-Hospital Nonvariceal Upper Gastrointestinal Bleeding following Cardiac Surgery: Patient Characteristics, Endoscopic Lesions and Prognosis. Amorim, Marcos; Barkun, Alan N.; Larocque, Martin; Herba, Karl; DeVarennes, Benoit; Martel, Myriam // Ulcers;2012, p1 

    Background. Nonvariceal upper gastrointestinal bleeding (NVUGIB) can occur following cardiac surgery, with sparse contemporary data on patient characteristics and predictors of outcome in this setting. Aim. To describe the clinical and endoscopic characteristics of patients with NVUGIB following...

  • Gastrointestinal Bleeding: Who Needs Urgent Endoscopic Intervention? McCarthy, Denis // Digestive Diseases & Sciences;Sep2013, Vol. 58 Issue 9, p2452 

    No abstract available.

  • Dabigatran etexilate.  // Reactions Weekly;6/8/2013, Issue 1456, p15 

    The article presents a case study of a 79-year-old man who developed severe coagulopathy and gastrointestinal bleeding while taking dabigatran etexilate.

  • Early Administration of Vapreotide for Variceal Bleeding in Patients with Cirrhosis. Calès, Paul; Masliah, Claude; Bernard, Brigitte; Garnier, Pierre-Philippe; Silvain, Christine; Bronowicki, Jean-Pierre; Szostak-Talbodec, Nathalie; Ribard, Didier; Botta-Fridlund, Danièle; Hillon, Patrick; Besseghir, Kamel; Lebrec, Didier; Poynard, Thierry; Verger, Pierre; Paris, Jean-Claude; Durand, Francois; Valla, Dominique-Charles; Lemaire, Alex; Rouch, Michel; Blanchi, Alain // New England Journal of Medicine;01/04/2001, Vol. 344 Issue 1, p23 

    Background: In patients with cirrhosis, pharmacologic or endoscopic treatment may control variceal bleeding. However, the effects of early administration of a somatostatin analogue followed by endoscopic treatment are unknown. Methods: We studied the effects of treatment with vapreotide, a...

  • Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Hearnshaw, Sarah A.; Logan, Richard F. A.; Lowe, Derek; Travis, Simon P. L.; Murphy, Mike F.; Palmer, Kelvin R. // Gut;Aug2010, Vol. 59 Issue 8, p1022 

    OBJECTIVES: To examine the use of endoscopy in the UK for acute upper gastrointestinal bleeding (AUGIB) and compare with published standards. To assess the organisation of endoscopy services for AUGIB in the UK. To examine the relationship between outcomes and out of hours (OOH) service...

  • Octreotide Use in Gastric Antral Vascular Ectasia. Lam, Alice; Lam, Skip SH; Chang, Denis WH; Badov, David // Journal of Pharmacy Practice & Research;Dec2013, Vol. 43 Issue 4, p297 

    Background: Gastric antral vascular ectasia (GAVE) accounts for 4% of non-variceal gastrointestinal bleeding. Argon Plasma Coagulation, an endoscopic therapy, is the treatment of choice, followed by medications and surgery. There is limited evidence for drug therapies, such as corticosteroids,...

  • Clinical and Endoscopic Risk Factors in the Mallory-Weiss Syndrome. Bharucha, A. E.; Gostout, C. J.; Balm, R. K. // American Journal of Gastroenterology;May1997, Vol. 92 Issue 5, p805 

    Objectives: Although patients with bleeding Mallory-Weiss tears are generally hospitalized, we wished to develop guidelines facilitating the selection, by clinical and endoscopic criteria, of patients who do not need hospitalization. Our specific aims were to determine whether presenting...

  • Long-Term Therapy With Bevacizumab in a Patient With Glanzmann's Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic Lesions. Marlu, Raphael; Barthelon, J; Durand, A; Mathieu, N; Barro, C; Granger, V; Tatu, A; Pernod, G; Polack, B; Bonaz, B // American Journal of Gastroenterology;Feb2015, Vol. 110 Issue 2, p352 

    The article discusses a case study of a 54-year-old woman with type I Glanzmann's thrombasthenia (GT) with gastro-intestinal bleeding caused due to multiple disseminated gastro-intestinal angiodysplastic lesions (GIADs) in stomach between August 2011 and April 2012. It informs that bevacizumab...


Read the Article


Sign out of this library

Other Topics